HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jinsong Liu Selected Research

oncrasin-1

4/2011Analogues and derivatives of oncrasin-1, a novel inhibitor of the C-terminal domain of RNA polymerase II and their antitumor activities.
9/2008Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jinsong Liu Research Topics

Disease

171Neoplasms (Cancer)
07/2022 - 08/2002
81Ovarian Neoplasms (Ovarian Cancer)
12/2021 - 03/2003
40Carcinoma (Carcinomatosis)
03/2022 - 09/2003
27Carcinogenesis
06/2015 - 03/2003
14Neoplasm Metastasis (Metastasis)
01/2022 - 07/2006
11Ovarian Epithelial Carcinoma
03/2017 - 02/2004
10Breast Neoplasms (Breast Cancer)
01/2021 - 09/2003
8Infections
01/2022 - 08/2003
8Endometrioid Carcinoma
06/2011 - 10/2003
5Osteoporosis
04/2022 - 12/2014
5Prostatic Neoplasms (Prostate Cancer)
01/2022 - 10/2006
5Polyploidy
01/2022 - 06/2013
5Insulin Resistance
01/2020 - 04/2008
5Lung Neoplasms (Lung Cancer)
01/2017 - 06/2009
5Ascites
03/2012 - 03/2004
4Endometrial Neoplasms (Endometrial Cancer)
12/2021 - 07/2006
4Cystadenoma
01/2014 - 10/2004
4Microsatellite Instability
11/2006 - 10/2003
3Bone Resorption
11/2021 - 12/2014
3Adenocarcinoma
02/2016 - 10/2006
3Mucinous Adenocarcinoma (Mucinous Carcinoma)
01/2015 - 01/2008
3Noninfiltrating Intraductal Carcinoma (DCIS)
01/2014 - 09/2003
3Genomic Instability
07/2013 - 06/2010
3Hypoxia (Hypoxemia)
06/2013 - 02/2007
3Colorectal Neoplasms (Colorectal Cancer)
09/2009 - 10/2003
3Type 2 Diabetes Mellitus (MODY)
03/2009 - 04/2008
3Motion Sickness (Airsickness)
02/2006 - 05/2004
3Granulosa Cell Tumor
10/2005 - 06/2003
2Diarrhea
06/2022 - 02/2009
2Dyspepsia (Indigestion)
06/2022 - 01/2021
2AIDS-Related Complex (ARC)
04/2022 - 01/2014
2Metabolic Diseases (Metabolic Disease)
01/2022 - 03/2017
2Weight Loss (Weight Reduction)
01/2022 - 08/2019

Drug/Important Bio-Agent (IBA)

49Proteins (Proteins, Gene)FDA Link
06/2022 - 08/2003
18Small Interfering RNA (siRNA)IBA
01/2018 - 08/2003
16Messenger RNA (mRNA)IBA
09/2021 - 02/2004
12Pharmaceutical PreparationsIBA
01/2022 - 04/2011
11Paclitaxel (Taxol)FDA LinkGeneric
09/2021 - 04/2003
9Biological ProductsIBA
01/2022 - 03/2004
9Biomarkers (Surrogate Marker)IBA
01/2018 - 11/2005
8CytokinesIBA
01/2021 - 03/2004
7Estrogens (Estrogen)FDA Link
05/2017 - 04/2003
7MicroRNAs (MicroRNA)IBA
05/2016 - 01/2011
7Telomerase (Telomerase Reverse Transcriptase)IBA
12/2008 - 03/2003
6LigandsIBA
01/2022 - 11/2004
6Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 04/2003
6Peptides (Polypeptides)IBA
01/2021 - 11/2004
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017 - 02/2004
6DNA (Deoxyribonucleic Acid)IBA
01/2015 - 11/2004
5AntioxidantsIBA
06/2022 - 03/2004
5Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 03/2004
5RNA (Ribonucleic Acid)IBA
03/2022 - 08/2003
5Interleukin-6 (Interleukin 6)IBA
09/2021 - 03/2004
5Estrogen ReceptorsIBA
01/2021 - 07/2004
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 02/2013
5Keratins (Keratin)IBA
11/2019 - 06/2003
5EnzymesIBA
01/2017 - 03/2004
5Phosphotransferases (Kinase)IBA
01/2017 - 05/2004
5Cisplatin (Platino)FDA LinkGeneric
07/2016 - 10/2005
5NF-kappa B (NF-kB)IBA
01/2016 - 03/2004
5Transcription Factors (Transcription Factor)IBA
08/2015 - 04/2006
5Antineoplastic Agents (Antineoplastics)IBA
01/2015 - 09/2008
5ErbB Receptors (EGF Receptor)IBA
11/2012 - 12/2006
5Hormones (Hormone)IBA
01/2011 - 01/2007
4ChemokinesIBA
01/2021 - 10/2006
4Phenobarbital (Luminal)FDA Link
01/2021 - 07/2006
4Interleukin-8 (Interleukin 8)IBA
01/2021 - 03/2004
4Androgen Receptors (Androgen Receptor)IBA
01/2021 - 12/2008
4AntigensIBA
01/2020 - 11/2005
4CalciumIBA
06/2017 - 12/2005
4Cyclin-Dependent Kinase Inhibitor p16IBA
03/2017 - 10/2006
4LipidsIBA
01/2017 - 07/2008
4ras ProteinsIBA
02/2009 - 08/2003
4ParaffinIBA
01/2008 - 06/2003
4AntibodiesIBA
01/2007 - 03/2004
4Cyclin D1IBA
01/2006 - 10/2002
3Capsules (Microcapsules)IBA
06/2022 - 07/2006
3TitaniumIBA
04/2022 - 01/2014
3Tumor Biomarkers (Tumor Markers)IBA
01/2021 - 05/2004
3ProlactinIBA
01/2020 - 06/2009
3lysophosphatidic acidIBA
01/2019 - 08/2004
3Inhibins (Inhibin)IBA
08/2017 - 06/2003
3Mitogen-Activated Protein KinasesIBA
01/2016 - 06/2009
3Focal Adhesion Protein-Tyrosine KinasesIBA
10/2013 - 12/2005
3Indicators and Reagents (Reagents)IBA
06/2013 - 05/2006
3Tumor Suppressor Protein p14ARF (p14ARF)IBA
06/2012 - 10/2006
3Aurora Kinase AIBA
02/2012 - 06/2010
3ProgesteroneFDA LinkGeneric
01/2011 - 03/2005
3AndrogensIBA
01/2011 - 03/2005
3beta CateninIBA
01/2010 - 10/2005
3Vasopressins (Vasopressin)IBA
02/2006 - 05/2004
2Volatile Fatty AcidsIBA
06/2022 - 01/2021
2AcidsIBA
06/2022 - 01/2022
2Monoamine Oxidase (MAO)IBA
04/2022 - 01/2014

Therapy/Procedure

48Therapeutics
07/2022 - 04/2003
24Drug Therapy (Chemotherapy)
03/2022 - 04/2003
5Neoadjuvant Therapy
03/2022 - 01/2015
4Radiotherapy
01/2021 - 10/2005
3Laparotomy
10/2018 - 08/2002
3Immunotherapy
01/2017 - 01/2007